The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...

Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...

While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...

Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine from the ...

The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...

The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.